✦ LIBER ✦

The treatment of acute lymphocytic leukemia

✍ Scribed by C.Gordon Zubrod

Book ID: 115960443
Publisher: Elsevier Science
Year: 1970
Weight: 268 KB
Volume: 22
Category: Article
ISSN: 0021-9681
DOI: 10.1016/0021-9681(70)90077-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The treatment of acute lymphocytic leuke

The treatment of acute lymphocytic leukemia: Editorial comment

✍ William L. Nyhan 📂 Article 📅 1966 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Lower incidence of meningeal leukemia wh

Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia

✍ Jones, Barbara ;Freeman, Arnold I. ;Shuster, Jonathan J. ;Jacquillat, Claude ;We 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 749 KB

In 1971, Cancer and Leukemia Group B (CALGB) mounted a study of acute lymphocytic leukemia (ALL) that compared the effects of the two steroid hormones dexamethasone and prednisone. Six-hundred-forty-six children and adolescents with ALL were randomized to receive either prednisone or dexamethasone a

10: Allogeneic Hematopoietic Stem Cell T

10: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Treatment of Acute Lymphocytic Leukemia (ALL) in 126 Adults: Impact of Donor Source on Leukemia Free Survival (LFS)

✍ Priya Kumar; Todd E. Defor; Claudio Brunstein; Juliet N. Barker; John E. Wagner; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 56 KB

The ninth annual david karnofsky lecture

The ninth annual david karnofsky lecture. Treatment of acute lymphocytic leukemia

✍ Donald Pinkel 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 881 KB

St. Jude Children's Research Hospital. The work I will present today represents 16 years of effort by the staff and employees of St. Jude, the courage and faith of children with leukemia and their families, and the generosity of our supporters. It also reflects the guidance of the man we

Fludarabine and cytosine arabinoside in

Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia

✍ Samer Suki; Hagop Kantarjian; Varsha Gandhi; Elihu Estey; Susan O'Brien; Milosla 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

## Background: The objectives of the study were to evaluate the antileukemic efficacy and toxicity profiles of the combination of fludarabine and intermediate-dose cytosine arabinoside (ara-c) in refractory or relapsed adult acute lymphocytic leukemia (all). patients and methods. thirty adults with

Mitoxantrone and high-dose cytosine arab

Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia

✍ Hagop M. Kantarjian; Ronald L. Walters; Michael J. Keating; Elihu H. Estey; SUSA 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB 👁 2 views

Twenty-five adult patients with refractory acute lymphocytic leukemia received salvage therapy with mitoxantrone 5 mg/m2 intravenously over 1 hour daily for 5 days and cytosine arabinoside 3 g/m2 intravenously over 2 hours every 12 hours for six doses. Overall, nine patients (36%) achieved complete